期刊文献+

676株铜绿假单胞菌的分布及耐药性 被引量:5

Distribution and drug resistance of 676 Strains of Pseudomonas aeruginosa
下载PDF
导出
摘要 目的探讨铜绿假单胞菌临床分离株的分布及耐药特征,为临床合理使用抗菌药物提供依据。方法回顾性地对医院2007年1月至2011年12月临床分离的676株铜绿假单胞菌的临床分布及药敏结果进行分析。结果 676株铜绿假单胞菌临床分布比较广泛,呼吸内科(26%)、老干部病房(17.6%)、ICU(10.7%)的患者感染率较高。感染部位以呼吸道为主,占78.1%。5年来铜绿假单胞菌对复方新诺明的耐药率最高(约80%);对亚胺培南的耐药率最低,保持在10%以下;对其他10种抗菌药物的耐药率有上升趋势。结论铜绿假单胞菌是临床常见的致病菌,我们应继续加强对铜绿假单胞菌耐药性的监测,指导临床合理使用抗生素,控制耐药菌株的扩散。 Objective To investigate the distribution and drug resistance of Pseudomonas aeruginosa(PAE),and to provide basis for the use of drugs in clinic.Methods The distribution and drug resistance of 676 strains of PAE isolated clinically from Jan.2007 to Dec.2011 was retrospectively analyzed.Results The 676 strains of PAE distributed extensively in clinic.The infection rate of PAE was found to be higher in the Departmetn of Respiratory Medicine(26%),Old Cadre Ward(17.6%) and ICU(10.7%) than in other departments.The main infected site was respiratory tract,accounting for 78.1%.During the last 5 years,the drug resistance rate of to SXT was the highest(about 80%),and that to imipenem was the lowest(remaining below 10%).The drug resistance of PAE to other 10 kinds of drugs showed a rising trend.Conclusion PAE is a common pathogenic bacteria in clinic.We should strengthen the monitoring of its drug resistance to provide guidance for reasonable use of antibiotics and rational control of drug-resistant strains.
出处 《海南医学》 CAS 2012年第10期103-104,共2页 Hainan Medical Journal
关键词 铜绿假单胞菌 抗菌药物 耐药性 合理用药 Pseudomonas aeruginosa Antibacterial drugs Drug resistance Reasonable use of antibiotics
  • 相关文献

参考文献5

二级参考文献24

共引文献117

同被引文献38

  • 1明德松,吴一波,朱焱,谢尊金.铜绿假单胞菌耐碳青酶烯类抗菌药物机制分类检测的研究[J].中华医院感染学杂志,2005,15(2):215-216. 被引量:40
  • 2郭小惠,张丽萍.铜绿假单胞菌耐药机制的最新研究进展[J].中华医院感染学杂志,2011,32(9):968-970.
  • 3曹丽华.慢性阻塞性肺疾病呼吸道粘液纤毛清除功能与细菌感染相关性的研究[D].沈阳:中国医科大学,2010.
  • 4Clinical and Laboratory Standards Institute. Performance standards for antimierobial susceptibility testing: twenty informational supple- ment [S]. MIO0-S21. CLSI, 2011.
  • 5Roux D, Ricard JD. Novel therapies for Pseudomonas aeruginosa pneumonia [J]. Infect Disord Drug Targets, 2011, 11(4): 389-394.
  • 6Riem E, Cabot G, Mulet X, et al. Pseudomonas aeruginosa earbapen- em resistance mechanisms in spain: impact on the activity of imipe- nero, meropenem and doripenem [J]. Antimicrob Chemother, 2011, 66(9): 2022-2027.
  • 7Cambrary G, Gucrout AM, Mazel D, et al. Integrons [J]. Annu Rcv Genet, 2010, 44: 141-166.
  • 8Attila C,Ue.xla A, Wood TK. PA2663 (PpyR) increases biofilm for- marion in Pseudomonas aeruginosa PAOI through the psloperon and stimulates virulence and quorum-sensing phcnotypes [J]. Appl Mi- crobiol Biotechnol, 2008, 78: 293-307.
  • 9Zavascki AP, Carvalhaes CG, Picao RC, et al. Multidrug-resistartt Pseudomona.s aeruginosa and A. baumannii: resistaate mechanisms and implications for therapy [J]. Expelrt Rev Anti Infect Ther, 2010, 8(1): 71-93.
  • 10陈亮,郑颖,马冬媛,辛续丽,韩静,王岩.耐亚胺培南铜绿假单胞菌医院感染现状及耐药性分析[J].中华医院感染学杂志,2009,19(9):1131-1132. 被引量:12

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部